Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Phase 2 Terminated Genzyme, a Sanofi Company

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to examine the safety and effectiveness of implanted skeletal muscle cells (cells removed from the thigh muscle) into scarred areas of heart muscle after heart attack.

Timeline

Start: 2002-11
Primary completion: 2007-04
Completion: 2007-04

Outcome

Outcome not reported

Stopped: “DMC recommended stop”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cultured Autologous Skeletal Myoblast Transplantation	Cell therapy	—	Other

Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Summary

Timeline

Outcome

Drugs

Indications